Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Analysts bullish on medtech due to strong fundamentals

Published 30/05/2023, 16:24
Updated 30/05/2023, 16:24
© Reuters.

© Reuters.

Both Morgan Stanley and BofA released bullish notes regarding medical technology on Tuesday.

BofA analysts told investors that medtech stocks are on sale, while the fundamentals are the best in three years, and that they see the sector as ownable.

"Medtech sold off post Q1 as investors realized Q1 rev beats had catchup/easy Jan comps, y/y growth is decelerating and rev beats will get smaller (and some flows into Tech sector)," wrote the analysts.

"Over the last month medtech is down 6%, S&P500 +1%, S&P Tech +9%. Elective medtech companies with Jan beat Q1 revs by 500-700bps and MDT, which didn't have Jan, beat by 90bps," they added. "ISRG said 6-7 points of its 26% Q1 procedure growth came from one timers and ISRG is seeing some of the best momentum in medtech suggesting one timers likely drove closer to a third or more of Q1 growth for the rest of elective medtech and most of the outsized upside vs Street."

Meanwhile, Morgan Stanley analysts said that volumes are in a healthy place, with Q1 beats almost across the board.

They added that there have been new muscles built around pricing, and they think Medtech fundamentals are strong. However, the analysts noted that the current valuation keeps them with an in-line view.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.